- NEGATIVE
Quarterly Revenue Vaxtex Cotfab Jun-2026 Quarterly Revenue is Rs 0 Cr which is growth of -94.9% YoY.
- NEGATIVE
Quarterly Net Profit Vaxtex Cotfab Jun-2026 Quarterly Net Profit is Rs -0 Cr which is growth of -123.9% YoY.
1.600.06(3.90%)
139.3K
NSE Volume
NSE 03 Nov, 2026 3:31 PM (IST)
Vaxtex Cotfab quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Vaxtex Cotfab quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0.5 | 10.4 | 3 | 0.5 | 6.3 | 0 | 0 | 0 | 0 | 2.1 | 4.1 | 10.9 | ||
Operating Exp. | 0.1 | 0.1 | 6.6 | 2.4 | 0.2 | 5.4 | 0.4 | 0.1 | -0.1 | 0.8 | 10.7 | 3.9 | 10.3 | |
Operating Profit | -0.1 | -0.1 | 2.3 | -0.1 | -0.2 | -0.1 | -0.4 | -0.1 | 0.1 | -1.2 | -8.6 | 0.2 | 0.5 | |
Operating Profit Margin % | - | - | 26.07% | -5.00% | - | -1.84% | - | - | - | 305.41% | -415.37% | 4.27% | 4.97% | |
Depr. | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.1 | 0.1 | ||||||
Interest | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | -0.1 | 0.4 | 3.9 | 0.6 | 0.2 | 0.9 | -0.4 | -0.1 | 0.1 | -0.8 | -8.6 | 0.1 | 0.5 | |
Tax | -0 | -0.4 | -0.1 | 0 | -0.4 | -0.1 | -0.2 | 0 | 0.1 | |||||
Net Profit | -0.1 | 0.8 | 4 | 0.6 | 0.2 | 1.3 | -0.4 | -0.1 | 0.1 | -0.7 | -8.6 | 0.1 | 0.4 | |
EPS Adj. latest | 0 | 0.2 | 0 | 0 | 0.1 | -0 | -0 | -0 | -0.5 | 0 | ||||
Net profit TTM | 5.3 | 5.5 | 6.1 | 1.7 | 1 | 0.9 | -1.1 | -9.3 | -9.1 | -8.8 | -8 | 0.7 | 0.8 | |
Basic EPS TTM | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | -0.1 | -0.5 | -0.5 | -0.5 | -0.4 | 0 | 0.1 | |
Earnings Transcripts |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Vaxtex Cotfab competitor comparison and performance snapshot within industry
Vaxtex Cotfab annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Vaxtex Cotfab Mar-2026 Annual Revenue is Rs 14 Cr which is growth of 126.0% YoY.
- POSITIVE
Annual Net Profit Vaxtex Cotfab Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of 525.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-42.7% | -11.3% | 14 | 14.4 | 6.4 | 17.2 | 76.5 | 62.3 | 26.2 | 27.8 | 22 | 18.5 | 4.5 | 0.7 | ||
Operating Exp. Ann. | -50.4% | -17.7% | 9.1 | 9.3 | 5.8 | 25.8 | 76 | 58.9 | 24.7 | 26.4 | 21 | 18.1 | 4.4 | 0.6 | |
Operating Profit Ann. | - | 6.3% | 2 | 1.9 | -0.5 | -9.1 | -0.4 | 3 | 1.4 | 1.4 | 1 | 0.4 | -0.1 | -0 | |
OPM Ann. % | - | 19.2% | 13.16% | -7.85% | -53.32% | -0.50% | 4.83% | 5.47% | 4.93% | 4.33% | 2.04% | -1.96% | -2.61% | ||
-50.4% | -18.4% | 9.4 | 6 | 26 | 76.9 | 60.3 | 26 | 27.6 | 21.1 | 18.2 | 4.4 | 0.6 | |||
EBITDA Ann. | 118.3% | 28.2% | 5.2 | 0.6 | -8.6 | 0.5 | 3.4 | 1.5 | 1.4 | 1 | 0.4 | 0.1 | 0 | ||
EBITDA Ann. margin % | 276.5% | 44.3% | 35.75% | 9.84% | -50.25% | 0.67% | 5.43% | 5.72% | 5.00% | 4.53% | 2.04% | 1.13% | 1.74% | ||
Interest Ann. | -45% | -38.1% | 0.1 | 0.1 | 0.1 | 0.1 | 0.6 | 1.1 | 1.1 | 1.1 | 0 | ||||
Depr. | - | - | 0 | 0 | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | ||
PBT Ann. | 62% | 76.2% | 4.8 | 5.1 | 0.4 | -8.8 | 1.2 | 2 | 0.3 | 0.2 | 0.9 | 0.3 | 0 | 0 | |
Tax Ann. | - | - | -0.5 | -0.5 | -0.5 | 0 | 0.5 | 0.1 | 0.1 | 0.3 | 0.1 | 0 | |||
71% | 94% | 5.5 | 0.9 | -8.8 | 1.1 | 1.5 | 0.2 | 0.1 | 0.6 | 0.2 | 0 | 0 | |||
Net Profit Ann. | 71% | 94% | 5.3 | 5.5 | 0.9 | -8.8 | 1.1 | 1.5 | 0.2 | 0.1 | 0.6 | 0.2 | 0 | 0 | |
NPM Ann. % | 221.4% | 135.7% | 49.48% | 16.81% | -53.15% | 1.49% | 2.39% | 0.68% | 0.33% | 2.73% | 0.92% | 0.42% | 1.24% | ||
EPS Adj. latest Ann. | 44.2% | - | 0.3 | 0.1 | -0.5 | 0.1 | 0.1 | 0 | 0 | 0 | 0 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
125%
2Y CAGR
-8.5%
3Y CAGR
-42.7%
5Y CAGR
-11.3%
7Y CAGR
-5.9%
10Y CAGR
35.3%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
511.1%
3Y CAGR
71%
5Y CAGR
94%
7Y CAGR
37.2%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
60.3%
2Y CAGR
-40%
3Y CAGR
-50.4%
5Y CAGR
-17.7%
7Y CAGR
-11%
10Y CAGR
31.5%
Operating Expenses Annual Cr growth is higher than historical averages.
Vaxtex Cotfab balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Vaxtex Cotfab Mar-2026 Total Shareholders Fund is Rs 22 Cr which is growth of 22.4% YoY.
- NEGATIVE
Total Assets Vaxtex Cotfab Mar-2026 Total Assets is Rs 37 Cr which is growth of -24.0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-1.6% | 20.3% | 22.4 | 18.3 | 18.8 | 23.5 | 10.4 | 8.9 | 8.7 | 4.7 | 4.1 | 4 | 3.9 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
-29.4% | -28.7% | 1.9 | 7.4 | 10.3 | 5.4 | 6.3 | 10.3 | 9.4 | 3 | 0.3 | 0 | |||
-32.5% | 38% | 12.5 | 22.8 | 19.8 | 40.6 | 7.4 | 2.5 | 9.9 | 5.8 | 5.8 | 0.7 | 0.3 | ||
Total Capital Plus Liabilities Ann. | -19.1% | 11.1% | 36.8 | 48.5 | 48.9 | 69.5 | 24 | 21.7 | 27.9 | 13.5 | 10.2 | 4.7 | 4.2 | |
-36.5% | -16.1% | 1 | 1.1 | 3.7 | 3.9 | 3.9 | 2.4 | 1.8 | 1.7 | 0.4 | ||||
-31.3% | -32.7% | 1.2 | 7.6 | 7.1 | 3.7 | 4 | 8.7 | 11.2 | 6.3 | 1.8 | 0.4 | 3.6 | ||
-18.5% | 22.3% | 35.6 | 40.9 | 41.8 | 65.8 | 20 | 13 | 16.8 | 7.3 | 8.4 | 4.3 | 0.6 | ||
Total Assets Ann. | -19.1% | 11.1% | 36.8 | 48.5 | 48.9 | 69.5 | 24 | 21.7 | 27.9 | 13.5 | 10.2 | 4.7 | 4.2 | |
Contingent Liabilities plus Commitments Ann. | 15.3% | - | 4.9 | 4 | 3.2 | 3.2 | 1.3 | 1.3 | 1.3 | 1.3 | ||||
Bonus Equity Share Capital Ann. | 0% | 3.7% | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4 | 4 | |||||
Non Current Investments Unquoted Book Value Ann. | 0% | - | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||||
Current Investments Unquoted Book Value Ann. | - | - | 1.2 | 1.1 | 1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-24.1%
2Y CAGR
-13.3%
3Y CAGR
-19.1%
5Y CAGR
11.1%
7Y CAGR
15.4%
10Y CAGR
24.2%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-45.2%
2Y CAGR
-20.5%
3Y CAGR
-32.5%
5Y CAGR
38%
7Y CAGR
11.6%
10Y CAGR
45.2%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
22.4%
2Y CAGR
9.2%
3Y CAGR
-1.6%
5Y CAGR
20.3%
7Y CAGR
25%
10Y CAGR
19.1%
Total ShareHolders Funds Annual growth is stable compared to historical averages.
Vaxtex Cotfab ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Vaxtex Cotfab Mar-2026 Book Value Per Share is 1 Rs which is growth of 22.4% YoY.
- POSITIVE
ROE Vaxtex Cotfab Mar-2026 ROE is 25% which is growth of 19.8% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | -14.2% | -39.4% | 1.2 | 1 | 1 | 1.9 | 2.1 | 14.7 | 14.4 | 117.5 | 102.5 | 98.3 | 97.8 | |
RoA Ann. % | 110% | 78.8% | 15.00% | 1.82% | -18.07% | 1.62% | 6.19% | 0.82% | 0.33% | 4.45% | 1.67% | 0.39% | 0.18% | |
ROE Ann. % | 72.2% | 65.2% | 24.62% | 4.81% | -47.01% | 4.82% | 14.34% | 2.00% | 1.07% | 12.73% | 4.14% | 0.46% | 0.19% | |
ROCE Ann. % | 197.8% | 24.6% | 21.13% | 2.03% | -30.18% | 0.80% | 18.53% | 7.04% | 6.89% | 11.53% | 6.21% | 0.97% | 0.28% | |
Total Debt to Total Equity Ann. | 0% | -30.1% | 0.2 | 0.6 | 0.6 | 0.2 | 0.7 | 1.2 | 1.5 | 0.7 | 0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
411.9%
3Y CAGR
72.2%
5Y CAGR
65.2%
7Y CAGR
9.9%
10Y CAGR
62.6%
ROE Annual % is growing faster than historical averages.
RoA Ann. %
1Y CHG
724.2%
3Y CAGR
110%
5Y CAGR
78.8%
7Y CAGR
19%
10Y CAGR
55.6%
RoA Annual % is growing faster than historical averages.
Current Ratio Ann.
1Y CHG
55.6%
2Y CAGR
15.5%
3Y CAGR
20.5%
5Y CAGR
-11.3%
7Y CAGR
11.6%
10Y CAGR
2%
Current Ratio Annual growth is higher than historical averages.
Vaxtex Cotfab cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Vaxtex Cotfab Mar-2026 Cash From Operating Activity is Rs -2 Cr which is growth of -277.7% YoY.
- POSITIVE
Net Cash Flow Vaxtex Cotfab Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 362.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -2.2 | 1.2 | -13.1 | -10.9 | 2.2 | 0.9 | -7.4 | 1.7 | 1.5 | -3.4 | 0.1 | ||
Cash from Investing Act. Ann. | 168.4% | 19.3% | 5.8 | -0.8 | -3.2 | 0.3 | -1.1 | 2.4 | -5.1 | -4.6 | -1.4 | 3.2 | ||
Cash from Financing Act. Ann. | - | - | -3.6 | -0.5 | 16.2 | 10.5 | -1.1 | -3.4 | 12.1 | 3 | 0.3 | 0 | ||
- | - | 0.1 | -0 | -0.1 | -0.1 | 0 | -0.1 | -0.3 | 0.2 | 0.3 | -0.2 | 0.2 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Investing Act. Ann.
3Y CAGR
168.4%
5Y CAGR
19.3%
Cash from Investing Activity Annual growth is higher than historical averages.
